Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. Receives Patent Grants in Additional European Territories

DOYLESTOWN, Pa., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development...
June 30, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. Bolsters IP Portfolio with Multiple Patents Issued in 12 Key European Territories

DOYLESTOWN, Pa., June 30, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical and medchem company specializing in the research and development...
June 02, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. Appoints Terrence O. Tormey to the Company’s Board of Advisors

DOYLESTOWN, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
April 28, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. CEO Op-Ed Featured in Green Entrepreneur Magazine’s Latest Edition

DOYLESTOWN, Pa., April 28, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
April 16, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. CEO Featured in OTCQB Podcast Discussing KLS-13019 and Its Potential Role as a Non-Opioid Treatment for Neuropathic Pain

DOYLESTOWN, Pa., April 16, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
April 14, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. Announces Results from Comparative UVB-Radiation Study on Atopidine™ Versus CBD

DOYLESTOWN, Pa., April 14, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
April 01, 2020 11:23 ET | Source: Kannalife, Inc.

UPDATE – Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™

DOYLESTOWN, Pa., April 01, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of...
March 18, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. Receives Seventh Patent by Extending Patent Family to Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders

DOYLESTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical med-chem company specializing in the research and development of...
March 03, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife, Inc. Receives Patent in the European Union (EU) for its Novel Monotherapeutic Compound to Treat CNS and PNS Disorders

DOYLESTOWN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical med-chem company specializing in the research and development of...
February 18, 2020 09:00 ET | Source: Kannalife, Inc.

Kannalife Bolsters its Global Intellectual Property Portfolio with New Chinese-Issued Patent

DOYLESTOWN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company specializing in the research and development of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right